Howard Berman - Feb 27, 2023 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Executive Officer, Director
Signature
/s/ David Snyder, Attorney-in-Fact
Stock symbol
COYA
Transactions as of
Feb 27, 2023
Transactions value $
$0
Form type
4
Date filed
3/1/2023, 03:05 PM
Previous filing
Jan 17, 2023
Next filing
Feb 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +165K $0.00 165K Feb 27, 2023 Common Stock 165K $3.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023.